Cellectricon

At Cellectricon, we create new avenues for neuroscience drug discovery. Our mission is to create groundbreaking concepts that will advance the neuroscience research field. From early concept evaluation to transformative drug discovery campaigns, we solve your scientific challenges through innovative approaches for in vitro research. We help you to: Obtain new insights into disease biology Accelerate the R&D process and reduce time to decision-making Identify targets and lead compounds with potential to produce first-in-class medicines Our unique discovery platform combines drug discovery expertise and disease area knowledge with cutting-edge technologies. With the platform, we create complex disease models and assays...

Field stimulation and voltage control assays,neurodegeneration,neuropsychiatry,high-capacity in vitro assays,customized assay development,phenotypic screening,target-based screeening,high-throughput transfection,preclinical compound validation,neuroplasticity,peripheral neuropathies,high content imaging,chronic pain,drug discovery,target discovery,lead discovery,contract research organization,cro,research services,and drug discovery services

Cellectricon operates in the Biotechnology industry.

Cellectricon's revenue is 11m - 100m

Cellectricon has 11 - 50 employees.